07-05-2022 11:51 AM | Source: Dion Global Solutions Ltd
Marksans Pharma spurts as board to mull share buyback
Marksans Pharma jumped 10.30% to Rs 47.65 after the company said that its board will consider a share buyback on Friday, 8 July 2022. As on 31 March 2022, promoters held 48.25% stake in the company. On a consolidated basis, the company reported a 62.7% fall in net profit to Rs 29.65 crore despite of a 26.6% rise in net sales to Rs 418.04 crore in Q4 FY22 over Q4 FY21. Marksans Pharma is an Indian pharmaceutical company having a global footprint. The company's strengths lie in research, manufacturing and marketing of finished dosage pharmaceutical formulations.
Latest News
RBI lists 6 factors powering India`s take-off to bec...
RBI sees India`s GDP growth trend surging past 7 per...
Randeep Hooda opens up on next directorial: Maybe I ...
Olympic Selection Trials: Ashi Chouksey , Swapnil ta...
Indian chess body AICF exploring possibilities of ho...
FIIs stood as net sellers in equities as per April 2...
Internet subscribers reach 936.16 million in India, ...
Post-market comment by Mandar Bhojane, Choice Broking
Daily Market Analysis : Markets edged higher for the...
54 pc Indian workers predict key shift in their role...